Josefine Atzendorf1, Christian Rauschert, Nicki-Nils Seitz, Kirsten Lochbühler, Ludwig Kraus. 1. IFT Institut für Therapieforschung (Institute for Therapy Research), München; Department of Public Health Sciences, Centre for Social Research on Alcohol and Drugs, Stockholm University, Stockholm, Schweden; Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Ungarn.
Abstract
BACKGROUND: Prevalence estimates of the use of tobacco, alcohol, illegal drugs, and psychoactive medications and of substance-related disorders enable an assessment of the effects of substance use on health and society. METHODS: The data used for this study were derived from the 2018 Epidemiological Survey of Substance Abuse (Epidemiologischer Suchtsurvey, ESA). The sample of the German adult population comprised 9267 persons aged 18 to 64 (response rate, 42%). Population estimates were obtained by extrapolation to a total resident population of 51 544 494 people. RESULTS: In the 30 days prior to the survey, 71.6% of the respondents (correspond- ing to 36.9 million persons in the population) had consumed alcohol, and 28.0% (14.4 million) had consumed tobacco. 4.0% reported having used e-cigarettes, and 0.8% reported having used heat-not-burn products. Among illegal drugs, cannabis was the most commonly used, with a 12-month prevalence of 7.1% (3.7 million), followed by amphetamines (1.2%; 619 000). The prevalence of the use of anal- gesics without a prescription (31.4%) was markedly higher than that of the use of prescribed analgesics (17.5%, 26.0 million); however, analgesics were taken daily less commonly than other types of medication. 13.5% of the sample (7.0 million) had at least one dependence diagnosis (12-month prevalence). CONCLUSION: Substance use and the consumption of psychoactive medications are widespread in the German population. Substance-related disorders are a major burden to society, with legal substances causing greater burden than illegal substances.
BACKGROUND: Prevalence estimates of the use of tobacco, alcohol, illegal drugs, and psychoactive medications and of substance-related disorders enable an assessment of the effects of substance use on health and society. METHODS: The data used for this study were derived from the 2018 Epidemiological Survey of Substance Abuse (Epidemiologischer Suchtsurvey, ESA). The sample of the German adult population comprised 9267 persons aged 18 to 64 (response rate, 42%). Population estimates were obtained by extrapolation to a total resident population of 51 544 494 people. RESULTS: In the 30 days prior to the survey, 71.6% of the respondents (correspond- ing to 36.9 million persons in the population) had consumed alcohol, and 28.0% (14.4 million) had consumed tobacco. 4.0% reported having used e-cigarettes, and 0.8% reported having used heat-not-burn products. Among illegal drugs, cannabis was the most commonly used, with a 12-month prevalence of 7.1% (3.7 million), followed by amphetamines (1.2%; 619 000). The prevalence of the use of anal- gesics without a prescription (31.4%) was markedly higher than that of the use of prescribed analgesics (17.5%, 26.0 million); however, analgesics were taken daily less commonly than other types of medication. 13.5% of the sample (7.0 million) had at least one dependence diagnosis (12-month prevalence). CONCLUSION: Substance use and the consumption of psychoactive medications are widespread in the German population. Substance-related disorders are a major burden to society, with legal substances causing greater burden than illegal substances.
Authors: Suman Chandra; Mohamed M Radwan; Chandrani G Majumdar; James C Church; Tom P Freeman; Mahmoud A ElSohly Journal: Eur Arch Psychiatry Clin Neurosci Date: 2019-01-22 Impact factor: 5.270
Authors: Ludwig Kraus; Alexander Pabst; Daniela Piontek; Gerrit Gmel; Kevin D Shield; Hannah Frick; Jürgen Rehm Journal: Eur Addict Res Date: 2015-05-05 Impact factor: 3.015
Authors: Tim Stockwell; Jinhui Zhao; Thomas Greenfield; Jessica Li; Michael Livingston; Yang Meng Journal: Addiction Date: 2016-04-21 Impact factor: 6.526
Authors: G Lachner; H U Wittchen; A Perkonigg; A Holly; P Schuster; U Wunderlich; D Türk; E Garczynski; H Pfister Journal: Eur Addict Res Date: 1998-03 Impact factor: 3.015
Authors: Amy Peacock; Janni Leung; Sarah Larney; Samantha Colledge; Matthew Hickman; Jürgen Rehm; Gary A Giovino; Robert West; Wayne Hall; Paul Griffiths; Robert Ali; Linda Gowing; John Marsden; Alize J Ferrari; Jason Grebely; Michael Farrell; Louisa Degenhardt Journal: Addiction Date: 2018-06-04 Impact factor: 6.526
Authors: Ludwig Kraus; Johanna K Loy; Nicolas Wilms; Anne Starker Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2021-05-12 Impact factor: 1.513
Authors: Udo Bonnet; Michael Specka; Michael Soyka; Thomas Alberti; Stefan Bender; Torsten Grigoleit; Leopold Hermle; Jörg Hilger; Thomas Hillemacher; Thomas Kuhlmann; Jens Kuhn; Christian Luckhaus; Christel Lüdecke; Jens Reimer; Udo Schneider; Welf Schroeder; Markus Stuppe; Gerhard A Wiesbeck; Norbert Wodarz; Heath McAnally; Norbert Scherbaum Journal: Front Psychiatry Date: 2020-10-26 Impact factor: 4.157
Authors: Maximilian Christian Schielein; Linda Tizek; Barbara Schuster; Stefanie Ziehfreund; Claudia Liebram; Kilian Eyerich; Alexander Zink Journal: J Clin Med Date: 2020-06-11 Impact factor: 4.241